Full Text View
Tabular View
No Study Results Posted
Related Studies
A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015K
This study has been completed.
Study NCT01486017   Information provided by Astellas Pharma Inc

First Received on December 1, 2011.   Last Updated on December 2, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bioavailability of ASP015K
Pharmacokinetics of ASP015K
Healthy Subjects
Interventions listed in this trial
ASP015K
Sponsors listed in this trial
Astellas Pharma Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services